Study of LY3938577 for type 1 diabetes
Treatments studied
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests an investigational drug called LY3938577 in healthy people and people with type 1 diabetes. It looks at how the drug affects the body and whether it might help control blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older with type 1 diabetes for at least 1 to 2 years
- Use an insulin pump or take daily insulin injections
- Have a body mass index (BMI) between 18 and 35
- No recent severe low blood sugar or hospital visits for blood sugar problems
- Not taking certain other diabetes medications (like GLP-1 agonists or SGLT2 inhibitors) in the last 3 months
- Good overall health with normal heart, liver, and kidney function
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial tests a new medicine, LY4057996, in people with type 1 or type 2 diabetes and in healthy volunteers. It aims to see if the drug is safe and how it works in the body.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
This early-stage study tests a new experimental drug (NNC0487-0111) designed to help regulate insulin levels in adults with type 2 diabetes. Researchers want to see if it works safely and effectively when combined with your current diabetes medications.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.